CSL Pehring, the world’s leading biopharmaceutical company, has opened its regional headquarters at the Dubai Science Park, a science-focused business park that is developing the local healthcare sector.

The opening ceremony was attended by Marcus Stempfli, Vice President and General Manager, CSL Pehring, Intercontinental Business Operations, Mohammed Hajjaj, General Manager, Middle East & Africa, CSL Pehring, and Marwan Abdul Aziz Janahi, General Manager, Dubai Science Park.

The opening of the new office reinforces the company’s presence in the Middle East and Africa, helping to provide better care for patients and raise awareness about treatment options available for critical medical situations.

Biomedicine is one of the fastest growing sectors in the pharmaceutical industry, with an annual growth rate of more than 10% compared with conventional medicines with a growth rate of 7%. The positive investment climate in the UAE and its attractiveness as a major hub for healthcare and pharmaceutical industries have encouraged many international companies to launch their own operations locally, especially in the specialized industries.

CSL Pehring is a leader in the $ 24 billion plasma market. The company’s commitment to innovation is reflected in the development of advanced therapies to reduce the risk of early cardiovascular disease, improve organ transplantation, treat sickle cell disease, thalassemia and autoimmune diseases.

Said Marwan Abdul Aziz Janahi, Director General of Dubai Complex for Science and Chairman of the work of the pharmaceutical industry sector team and medical equipment within the Dubai Industrial Strategy for the year 2030″The Dubai Science Park is proud to host leading companies such as CSL Pehring, and the opening of the company’s regional headquarters is in line with our strategy of attracting internationally renowned leading pharmaceutical and healthcare companies as part of our role in building a world-class healthcare industry, One of the national priorities for the vision of the UAE 2021. Thanks to its supportive collaborative environment and its many advantages, DSC has the ability to support CSL Pehring in achieving its objectives and providing the latest treatments to the people of the Gulf region. “